.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Sarvodaya Healthcare recently completed a strategic Sarvodaya Healthcare hospital acquisition by taking over Nayati Hospital in Mathura. This move follows the successful approval from the National Company Law Tribunal (NCLT) through the Insolvency and Bankruptcy Code process. Consequently, the group's total bed capacity has surged from 800 to 1,200 units. Furthermore, this expansion aims to provide advanced tertiary medical services to patients across western Uttar Pradesh.
The Mathura facility has a standalone capacity of 400 beds. Currently, the group expects the hospital to be fully operational by June 2026. Additionally, the management plans to introduce various super-specialty departments. For instance, the hospital will focus on cardiology, oncology, and neurosciences. Moreover, they intend to pursue prestigious quality accreditations like NABH and NABL to ensure world-class care standards.
The acquired facility features robust infrastructure designed for complex medical interventions. It includes 100 ICU beds and nine modular operation theatres. Furthermore, the hospital provides 24x7 emergency and trauma care alongside advanced diagnostic services. As a result of this acquisition, Sarvodaya Healthcare now manages a workforce of over 5,500 healthcare professionals. They are also planning significant investments in technology upgrades and clinical recruitment.
Group Chairman Rakesh Gupta noted that this development reflects a commitment to expanding access to affordable healthcare. Therefore, the group continues to build its footprint beyond the Delhi-NCR region into emerging urban centres. This strategy will likely strengthen the regional healthcare ecosystem significantly.
Q1: What is the new total bed capacity of the Sarvodaya Healthcare group?
Following the acquisition of the 400-bed Mathura facility, the group's total capacity has increased to 1,200 beds.
Q2: When will the newly acquired hospital in Mathura become operational?
The group expects the hospital to be fully operational by June 2026 after necessary infrastructure upgrades.
Q3: Which medical specialties will the Mathura facility focus on?
The hospital will provide super-specialty services in cardiology, oncology, orthopaedics, neurosciences, gastroenterology, and critical care.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Sarvodaya Healthcare has acquired Nayati Hospital in Mathura through the NCLT process, increasing its total group bed capacity to 1,200 across North India....
4 months ago
Following the admission of Union Health Minister JP Nadda to AIIMS Delhi for acute uneasiness, clinical teams utilized diagnostic coronary angiography and inpatient observation. This clinical review outlines acute triage pathways, procedural protocols, post-procedure observation, and long-term risk management.
Today
A multicenter MPOG database study of 289,047 cesarean delivery cases analyzed adherence to obstetric anesthesia best practices. General anesthesia avoidance reached 97.0%, while post-spinal vasopressor infusions (55.4%) and hypothermia prevention (56.7%) showed the lowest compliance, highlighting key targets.
Yesterday
India faces an acute deficit in deceased organ procurement despite rising transplant numbers. With nearly 90,000 patients waiting and deceased donations contributing only 18% of total transplants, healthcare professionals must actively dispel brain death misconceptions and streamline retrieval systems to save lives.
Today
Recent research assesses an automated pipeline for CT-based vertebral finite element analysis, revealing how boundary condition components—especially load-point assignment—impact fracture-load accuracy in spinal biomechanics.
Today
Diabetic kidney disease remains a major cause of renal failure despite renin-angiotensin system blockade. Learn how combining SGLT2 inhibitors, nonsteroidal MRAs, GLP-1 receptor agonists, and novel aldosterone synthase or endothelin inhibitors addresses residual cardiorenal risk.
Today
